Join our newsletter!
Emerald Bioscience is focused on developing novel ways to deliver cannabinoid-based drugs for specific indications with the aim of optimizing the clinical effects of such drugs while limiting potential adverse events. Sign up below to receive the latest news from Emerald Bioscience, including press releases, product development, scientific publications, events and financial reporting directly to your inbox.

Emerald Bioscience is part of the Emerald Group, which comprises multiple companies focused on developing pharmaceutical, botanical, and nutraceutical products providing wellness and medical benefits by interacting with the human body’s endocannabinoid system.
* indicates required